Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-03

Clinical Trial Update: Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding tiotropium to formoterol improves exercise tolerance in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Foradil (formoterol)
  • Spiriva (tiotropium)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Pulmonary Disease, Chronic Obstructive, Chronic Bronchitis | Phase 4 | Status: COMPLETED | Results posted: 2009-12-03